Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
As of 2026-04-10, Dermata Therapeutics Inc. (DRMA) trades at a current price of $1.24, marking a 2.07% gain from the prior close. This analysis looks at recent trading patterns, broader sector context, and key technical levels for DRMA to help investors understand near-term trading dynamics for the small-cap biotech stock. No recent earnings data is available for the company as of this writing, so current price action is being driven primarily by technical factors and broader market flows rather
Can Dermata (DRMA) Stock Go Higher | Price at $1.24, Up 2.07% - Institutional Buying
DRMA - Stock Analysis
3430 Comments
1679 Likes
1
Oscar
Daily Reader
2 hours ago
Makes following the market a lot easier to understand.
👍 123
Reply
2
Kashara
Consistent User
5 hours ago
Anyone else just stumbled into this?
👍 179
Reply
3
Diquon
Experienced Member
1 day ago
Free US stock insights with real-time data, expert analysis, and carefully selected opportunities designed to support stable portfolio growth and reduce investment risk. Our platform provides comprehensive market coverage and professional guidance to help you navigate the complex world of investing with confidence and clarity.
👍 283
Reply
4
Roselina
Returning User
1 day ago
A retracement could provide a better entry point for long-term investors.
👍 97
Reply
5
Ahnyx
Consistent User
2 days ago
Too late to take advantage now. 😔
👍 223
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.